These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 22658279)

  • 41. Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
    Sautois B; Fraipont V; Baudoux E; Fassotte MF; Hermanne JP; Jérusalem G; Bours V; Bosquée L; Schaaf-Lafontaine N; Paulus JM; Sondag D; Fillet G; Beguin Y
    Haematologica; 1999 Apr; 84(4):342-9. PubMed ID: 10190949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimization of CD34+ collection for autologous transplantation using the evolution of peripheral blood cell counts after mobilization with chemotherapy and G-CSF.
    Delamain MT; Metze K; Marques JF; Reis AR; De Souza CA; Lorand-Metze I
    Transfus Apher Sci; 2006 Feb; 34(1):33-40. PubMed ID: 16376618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful mobilization of peripheral blood stem cells using recombinant human stem cell factor in heavily pretreated patients who have failed a previous attempt with a granulocyte colony-stimulating factor-based regimen.
    Dawson MA; Schwarer AP; Muirhead JL; Bailey MJ; Bollard GM; Spencer A
    Bone Marrow Transplant; 2005 Sep; 36(5):389-96. PubMed ID: 15980882
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients.
    Isidori A; Tani M; Bonifazi F; Zinzani P; Curti A; Motta MR; Rizzi S; Giudice V; Farese O; Rovito M; Alinari L; Conte R; Baccarani M; Lemoli RM
    Haematologica; 2005 Feb; 90(2):225-31. PubMed ID: 15710576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma.
    Pavone V; Gaudio F; Guarini A; Perrone T; Zonno A; Curci P; Liso V
    Bone Marrow Transplant; 2002 Feb; 29(4):285-90. PubMed ID: 11896424
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
    Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature.
    Jacoub JF; Suryadevara U; Pereyra V; Colón D; Fontelonga A; Mackintosh FR; Hall SW; Ascensão JL
    Exp Hematol; 2006 Nov; 34(11):1443-50. PubMed ID: 17046563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A simplified approach to stem cell mobilization in multiple myeloma patients not previously treated with alkylating agents.
    Lerro KA; Medoff E; Wu Y; Seropian SE; Snyder E; Krause D; Cooper DL
    Bone Marrow Transplant; 2003 Dec; 32(12):1113-7. PubMed ID: 14647264
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unsuccessful stem cell remobilization for autologous transplantation is predicted by renal impairment and a stem cell yield ≤ 0.5 X 10(6) CD34+ cells/kg at first mobilization.
    Hill QA; Pearce R; Cook G
    Bone Marrow Transplant; 2012 Oct; 47(10):1372-3. PubMed ID: 22343671
    [No Abstract]   [Full Text] [Related]  

  • 50. Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma.
    Moskowitz CH; Glassman JR; Wuest D; Maslak P; Reich L; Gucciardo A; Coady-Lyons N; Zelenetz AD; Nimer SD
    Clin Cancer Res; 1998 Feb; 4(2):311-6. PubMed ID: 9516916
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Older age and capacity of colony forming unit in autologous peripheral derived hematopoietic cells.
    Civriz Bozdag S; Bay M; Ayyıldız E; Topcuoglu P; Ilhan O
    Transfus Apher Sci; 2012 Aug; 47(1):113-6. PubMed ID: 22633541
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predicting the successful peripheral blood stem cell harvesting.
    Demiriz IŞ; Bozdağ SC; Tekgündüz E; Uğur B; Durgun G; Koçubaba S; Altuntaş F
    Transfus Apher Sci; 2013 Jun; 48(3):411-4. PubMed ID: 23628357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The costs of mobilisation and collection of peripheral blood stem cells in multiple myeloma and lymphoma in an European country: results from The Gruppo Italiano Trapianto Midollo Osseo (GITMO) and Società Italiana di Emaferesi e Manipolazione Cellulare (SIdEM) survey.
    Pierelli L; Berto P; Accorsi P; Milone G; Lopatriello S; Aiello A; Iacopino P; Olivieri A; Rambaldi A; Bosi A
    Transfus Apher Sci; 2013 Dec; 49(3):615-22. PubMed ID: 23973731
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: A position-statement from the Turkish Society of Apheresis (TSA).
    Tekgündüz E; Arat M; Göker H; Özdoğu H; Kaynar L; Çağırgan S; Erkurt MA; Vural F; Kiki İ; Altuntaş F; Demirkan F;
    Transfus Apher Sci; 2017 Dec; 56(6):845-849. PubMed ID: 29153306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of large unstained cells in predicting successful stem cell collection in autologous stem cell transplantation.
    Merter M; Sahin U; Uysal S; Dalva K; Yuksel MK
    Transfus Apher Sci; 2023 Feb; 62(1):103517. PubMed ID: 35963811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG).
    Tekgündüz E; Demirkan F; Vural F; Göker H; Özdoğu H; Kiki İ; Aydoğdu İ; Kaynar L; Erkurt MA; Çağırgan S; Beşışık S; Dağdaş S; Koca E; Kadıköylü G; Gündüz E; Yılmaz M; Beköz H; Ural AU; Baştürk A; Arat M; Albayrak M; Öztürk E; Akyol A; Bolaman AZ; Nevruz O; Özkan HA; Özgür G; Altuntaş F
    Transfus Apher Sci; 2017 Dec; 56(6):804-808. PubMed ID: 29153305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors for a poor hematopoietic stem cell mobilization.
    Donmez A; Yilmaz F; Gokmen N; Tombuloglu M
    Transfus Apher Sci; 2013 Dec; 49(3):485-8. PubMed ID: 23693121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of the Sysmex SE9000 immature myeloid index and Sysmex R2000 reticulocyte parameters in optimizing the timing of peripheral blood stem cell harvesting in patients with lymphoma and myeloma.
    Gowans ID; Hepburn MD; Clark DM; Patterson G; Rawlinson PS; Bowen DT
    Clin Lab Haematol; 1999 Oct; 21(5):331-6. PubMed ID: 10646075
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mean fluorescence intensity (MFI) of beta2 integrin (CD11a and CD11b) expression on peripheral blood (PB) CD34-positive (CD34(+)) cells in steady state correlates inversely with the total amount of harvested CD34(+) cells.
    Masauzi N; Tanaka J; Kasai M; Yamada M; Saitoh S; Kawamura T; Tsutsumi Y; Obara S; Matsushima T; Hashino S; Asaka M; Imamura M; Kobayashi M
    Bone Marrow Transplant; 2003 Jun; 31(11):1069-70. PubMed ID: 12774064
    [No Abstract]   [Full Text] [Related]  

  • 60. Stem cell mobilization kinetics in elderly patients with multiple myeloma.
    Dogu MH; Batgi H; Erkurt MA; Hacioglu S; Tekgunduz E; Kaya E; Iskender D; Eren R; Kuku I; Altuntas F
    Transfus Apher Sci; 2018 Apr; 57(2):204-207. PubMed ID: 29439920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.